Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06307249
Title Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA (PTST_PALBEVA)
Acronym PTST_PALBEVA
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Lebanese University
Indications
Therapies
Age Groups: adult | senior
Covered Countries


No variant requirements are available.